what to avoid on semaglutide π₯ Eat and What to When Taking for Weight Loss: A Guide Top 12 Foods to Avoid
Description
The triple agonist retatrutide (targeting GLP-1, GIP, and glucagon receptors) is in Phase 3 trials with early data showing up to 24% body weight reduction potentially exceeding both current agents

The peptide is doing the same thing

One that political scientists Donald Stokes called Pasteur's Quadrant

Orforglipron Orforglipron is a new type of non-peptide GLP-1 receptor agonist developed by Eli Lilly

You might have metabolic syndrome if you have three or more of these conditions: High percentage of visceral fat High blood sugar High blood pressure High blood triglycerides Low HDL (good cholesterol) High blood pressure, rising cholesterol, and diabetes are all independent risk factors for heart disease, says cardiologist Jayne Morgan, M.D
